Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-14

FDA Approved: VIGABATRIN — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA page documents Actavis Pharma's original application for a generic Vigabatrin product, seeking approval to market a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)